New Clinical Trials on Insulin Glargine gives New Hope for those with Type-2 Diabetes
Insulin Glargine gives New Hope for those with Type-2 Diabetes in New Clinical Trials
Anti-Diabetic, Drug Research & Development API, Patent Expiration 2023 Tags: anti-diabetic Dec 31, 2015
Linagliptin Could be the Answer to Macrovascular Complications Type-2 Diabetics
Anti-Diabetic, Blood Glucose Regulator, Drug Research & Development API, Gliptin Tags: anti-diabeticLinagliptin Dec 01, 2015
A new study reveals that patients diagnosed with Type2-diabetes are at an increased risk of developing macrovascular and microvascular complications. Researchers are currently using a drug called Linagliptin which is an anti-diabetic drug that works by increasing the levels of incretins to help control blood sugar levels, especially after meals. According to reports, the cardiovascular[…]
Dapagliflozin FDA Approval for Type 2 Diabetes
Anti-Diabetic, Drug Research & Development API, FDA Approved 2014 Tags: anti-diabeticDapagliflozinHbA1ctype 2 Diabetes Jan 17, 2014
As an anti-diabetic medication and selective inhibitor of the sodium glucose co-transporter type 2 (SGLT2), Dapagliflozin is now approved by the FDA for the treatment of type 2 diabetes mellitus. The Dapagliflozin FDA approval was announced January 13, 2014, as the brand name Farxiga, which is marketed by Bristol-Myers Squibb. The unique ability of Dapagliflozin[…]
Liraglutide diabetes control is proven and leads to weight loss
Anti-Diabetic, Drug Research & Development API Tags: anti-diabeticDrug AdministrationLiraglutidetype 2 Diabetes Dec 28, 2010
Liraglutide Diabetes Control Liraglutide is a newly developed drug that is used to control the levels of blood glucose in patients suffering from type 2 Diabetes. In January 2010, the US Food and Drug Administration approved this drug for the treatment of patients with diabetes. Liraglutide was approved by the European Medicines Agency (EMEA) in[…]
Metformin Hydrochloride Studies
Anti-Diabetic, Blood Glucose Regulator, OTC and Compounding Product, TEVA API Tags: anti-diabeticLDLMetformin HydrochlorideObesitytype 2 Diabetes Dec 08, 2010
Metformin Hydrochloride is one of the most recommended medicines for the treatment of patients suffering from biguanide or type 2 Diabetes. According to recent studies, Metformin Hydrochloride reduces the LDL and triglyceride levels in the blood and hence it is one of the best medicines for diabetic patients who are also suffering with obesity. Studies[…]
Sulfonylurea Class Antidiabetic Drugs
Anti-Diabetic, Bulk Active Ingredient, Compounding API, OTC and Compounding Product Tags: anemiaanti-diabetictype 2 Diabetes Nov 23, 2010
Anti-diabetic drugs treat diabetes by lowering glucose levels in the blood. One class of anti-diabetic drugs that are used in the management of diabetes is Sulfonylurea. Sulfonylurea derivatives are used in the management of diabetes mellitus type 2. They act by increasing insulin release from the beta cells in the pancreas. Diabetes mellitus type 2[…]
